Mitochondria functionality and apoptosis were studied in peripheral blood lymphocytes (PBL) of human immunodeficiency virus type 1-infected children, with or without lipodystrophy (LD), who were receiving highly active antiretroviral therapy (HAART) and in PBL of healthy control subjects (HCs). By flow cytometry, mitochondrial (mt) membrane potential, mt mass, intra-mt cardiolipin distribution, and early and late apoptosis in fresh PBL or in PBL cultured with different stimuli were assessed. mtDNA content was evaluated in fresh PBL by an original double-competitive quantitative polymerase chain reaction method, which enabled direct quantification of the number of mtDNA copies present in human lymphocytes. PBL from LDpositive and LD-negative children and from HCs were similar in mt functionality and in their tendency to undergo apoptosis. mtDNA content was also similar in PBL of LD-positive children and HCs, suggesting that normal mt functionality and normal tendency to undergo apoptosis are present in PBL of children with HAART-associated LD.
Changes in body shape with a redistribution of body fat and glucose/lipid abnormalities have been described in human immunodeficiency virus (HIV) type 1-infected patients receiving antiretroviral therapy [1] . The clinical presentation of the fat redistribution syndrome, named lipodystrophy (LD), is variable but is frequently characterized by peripheral fat wasting, with or without truncal obesity. Available data in HIV-infected adults suggest that protease inhibitors (PIs) and nucleoside reversetranscriptase inhibitors (NRTIs), both components of highly active antiretroviral therapy (HAART), may play a role in the development of the LD syndrome [2] [3] [4] [5] [6] .
HIV-infected children receiving antiretroviral treatment may also experience LD, which is poorly described in childhood. Recent data suggest that LD may occur more frequently than previously thought and that children with LD have clinical features similar to those in adults. In a first report, LD was observed by clinical examination and objective anthropometric measurements (skin fold thickness) in 33.3% (13/39) of the children studied [7] . These patients had peripheral lipoatrophy, truncal lipohypertrophy, or combined LD; abdominal lipohypertrophy was the most frequent change detected. Another pediatric study that used dual-energy X-ray absorptiometry (DXA) showed a similar prevalence of LD (i.e., 28.6% [8/28] ) in antiretroviraltreated children [8] .
Mitochondria are thought to be at least partly responsible for the onset of LD [9] . Not only are these organelles the main source of ATP produced by oxidative phosphorylation, but they are also the final common pathway for a number of initiators of apoptosis [10] . Mitochondria have their own DNA and therefore can carry several genetic defects that result in human diseases. Intriguing interactions between mitochondrial (mt) DNA and the environment, including drugs, are now emerging [11, 12] . The enzyme that is responsible for mtDNA replication (g-polymerase) is inhibited to a varying extent by NRTIs [13, 14] . Thus, it has been speculated that NRTI-induced mt toxicity may be the initial insult from HAART leading to fat redistribution [9] .
Contrasting data exist concerning the role of mt toxicity in the onset of LD (reviewed in [15] ). On one hand, significant decreases in mtDNA amount were found in fat biopsy specimens or lymphocytes from patients with LD [16] [17] [18] ; however, Ware et al. [19] and Sekhar et al. [20] demonstrated that fat oxidation, an mt function, is normal or potentially increased in HAARTtreated subjects with metabolic disturbances. A study of muscle biopsy specimens before and after exercise and of lactate levels found normal oxidative phosphorylation with a similar recovery rate in lactate and pyruvate levels after exercise and absence of significant abnormalities in muscles' mitochondria [21] .
To verify the existence of possible association(s) between mt toxicity and the LD syndrome in pediatric patients, we studied fresh or cultured peripheral blood lymphocytes (PBL) from HAART-treated, vertically HIV-infected children with and without clinical evidence of LD. These cells were chosen because they are the site where antiviral therapy must act and because PBL are easy to obtain, even from small patients, during routine tests.
Subjects and Methods
Subjects. Eighteen vertically HIV-infected children and adolescents, aged 4-16 years, followed up by the chair of pediatrics at L. Sacco Hospital (Milan, Italy) were enrolled in the study. They had no severe concomitant illnesses, did not currently take corticosteroids, and had normal caloric intake for age and sex. Clinical characteristics of the patients are summarized in the Results section. As a control group, we studied 10 healthy control children (HCs) matched by age and sex to those in the experimental group. HCs were admitted for minor surgical procedures to the pediatric departments, University of Modena and Reggio Emilia (Modena, Italy). Blood was taken >1 month after surgery (HC visits).
Evaluation of body composition by DXA. Whole body composition was assessed by DXA (Lunar DPX-L; Lunar Radiation) equipped with pediatric software (version 1.5 e; Lunar Radiation). Scans were done with subjects in the supine position, as described elsewhere [22] ; the children did not require sedation. The entire body of each subject was scanned, beginning at the top of the head. A different scan mode was chosen with respect to each subject's body size, as suggested by the manufacturer's operator manual. Scanning was done with the "medium" scan mode (scan speed, 76.8 mm/s; sample size, 4:8 £ 9:6 mm; sample interval, 0.062 s; and source collimation, 1.68 mm) or with the "fast" scan mode (scan speed, 153.6 mm/s; sample size, 4:8 £ 9:6 mm; sample interval, 0.03 s; and source collimation, 1.68 mm), according to the child's size. Mean measurement time was 20 min; radiation exposure was ,8 mSv. Three-compartment analyses were performed in the arms, trunk, and legs. Arm and leg data were added and were expressed as limbs. Daily quality assurance tests were performed according to the manufacturer's directions. All scans were made and analyzed by the same operator. The precision of the instrument was 0.7% for fat and 0.9% for lean in normal-weight children. Anthropometry and DXA were done on the same day.
Chemicals. Cytofluorimetric analysis. Functional studies were performed on freshly collected PBL obtained after isolation of mononuclear cells on ficoll gradient and depletion of monocytes by incubation on plastic for 1 h at 37 C in culture medium containing 20% fetal calf serum (FCS). PBL were then incubated for different periods (<72 h) at 37 C in a humidified atmosphere (5% CO 2 in air) in RPMI 1640 medium supplemented with 10% FCS (vol/vol), 2 mM L-glutamine, 100 IU/mL penicillin, and 100 mg/mL streptomycin. At different time points, PBL were collected, treated, and stained, as described below. Apoptosis was induced by incubating cells with different stimuli, such as anti-CD95 MAb, anti-CD3 MAb, or SEB (50 ng/mL). Incubation with anti-CD95 MAb was for 48 h and that with the other molecules for 72 h.
For analysis of changes in mt membrane potential (Dc) after incubation with different agents, cells were treated as described above and, at the end of the incubation period, were stained with the Dc-sensitive probe JC-1, used for 10 min at room temperature in the dark at the concentration of 2.5 mg/mL in RPMI 1640 medium containing 10% FCS, as described elsewhere [23, 24] . Early apoptosis was analyzed by staining cells with FITC-conjugated Annexin V and Mitotracker CMX Ros Red; late apoptosis was analyzed by propidium iodide, as described elsewhere [25] .
Analysis of cardiolipin (CL) distribution. CL, a unique phospholipid with dimeric structure, is an essential molecule for the functionality of several mt proteins [26] . Its distribution between the inner and outer leaflet of the mt internal membrane is crucial for ATP synthesis. To analyze CL intra-mt distribution, we used a recently described method that is based on the spectral characteristics of nonyl acridine orange (NAO) [27] . We used its property to form dimers when interacting with diacidic phospholipid. Also, its fluorescence emission shifts from 525 nm (monomeric form of the dye) to 640 nm under dimeric conditions in the presence of a stoichiometric ratio of 2:1 with CL. In brief, cells were fixed in 1% formaldehyde (in PBS) for 15 min at room temperature, washed twice in cold PBS, and adjusted at 0:5 £ 10 6 cell/mL in PBS. Increasing amounts of NAO (0.1-35 mM) were added in separate tubes; cells were kept at room temperature for 15 min, washed twice with PBS, resuspended in a total volume of 400 mL of PBS, and analyzed. Because of the fixation and the high dose of the fluorescent probe, the physical parameters of monocytes and granulocytes largely overlapped in the dot plot representing forward and side scatter (data not shown). For this reason, we analyzed these 2 populations with a single gate and give a unique value to both cell types. The red and green fluorescence emission intensity was plotted as a function of the amount of NAO present in the incubation mixture; however, only the red fluorescence was used for analysis of CL distribution, as described elsewhere [27] .
Quantification of mtDNA by double-competitive polymerase chain reaction (QC-PCR). We used an original QC-PCR approach to determine the number of copies of mtDNA. The competitor for mtDNA was prepared by starting from total DNA extracted from the U937 cell line. A 180-bp fragment of the mt gene encoding for the subunit VI of F0F1 ATPase was amplified with primers mt192R (5 0 -GCTCTAGAAAGAGATCAGGTTCGTCCTTTAGTG-3 0 ) and mt27D (5 0 -AAAATGAACGAAAATCTGTTCGCT-3 0 ). An internal deletion of 20 bp was done with primer mt70D (5 0 -GGAATTCAA-AATGAACGAAAATCTGTTCGCTCCTACCCGCCGCAGTA-GTGA-3 0 ), which has a tail identical to that of primer mt27D. This PCR product can be amplified by using primers mt27D and mt192R and by wild-type DNA. Because it is 20 bp shorter, it can be easily distinguished from wild-type DNA on agarose gel. This fragment was cloned into the pFASL plasmid that contains the competitor for CD95L [28] , taking advantage of the consensus sequences for Eco RI and Xba I restriction enzymes present at both ends. The construct, named pMito, was extracted from Escherichia coli cells by use of a High Pure plasmid isolation kit, was quantified by spectrophotometer and limiting dilution analysis, and was stored at 220 C. This construct was used with QC-PCR to evaluate the number of copies of mtDNA or genomic DNA (gDNA) that are present in a sample, depending on the primers used in the PCR mix. mtDNA has been quantified by carrying out several PCR reactions with the same amounts of DNA extracted from the sample and scalar amounts of competitor DNA (10 8 -10 2 copies). Each tube contained 25 mL of a PCR mix consisting of dNTPs at 2.5 mM, primers mt27D and mt192R at 200 nM, MgCl 2 at 1.5 mM, Tris Cl at 50 mM (pH 9 at 25 C), and 1 U of Taq polymerase. Every PCR reaction was 50 cycles, and each cycle consisted of a denaturation step (94 C for 30 s), an annealing step (52 C for 30 s), and an extension step (72 C for 30 s) The first cycle was preceded by a denaturation step of 5 min at 94 C; the last was followed by an extension step of 7 min at 72 C. gDNA was quantified with the same technique and with the same competitor at identical concentrations and the same PCR mix; however, primers 276R and 60D [28] , instead of mt27D and mt276R, were added to the mix, and PCR cycling was slightly different: Each cycle consisted of a denaturation step (94 C for 30 s), an annealing step (56.5 C for 35 s), and an extension step (72 C for 40 s). The first cycle was preceded by a denaturation step of 5 min at 94 C, and the last was followed by an extension step of 7 min at 72 C. PCR products were loaded on a 3% agarose gel for 40 min at 90 V and were stained with EtBr 0.5 mg/mL; relative intensity of the 2 bands (competitor vs. wild type) was calculated by densitometer (GelDoc 2000; BioRad) with relative software (Multianalyst 1.0.1; BioRad). Fluorescence intensity of the competitor band was corrected by a factor of 1.10 (for mtDNA) or 1.16 (for gDNA), to compensate for minor EtBr incorporation. The number of copies of mtDNA per cell was calculated as the ratio between number of copies of mtDNA (obtained by the first PCR) and number of copies of gDNA (obtained by the second PCR), multiplied by 2 (2 copies of CD95L gene are obviously present in the gDNA). To obtain platelet-free PBL, blood was first centrifuged at low speed, then PBL were obtained as described above and were incubated for another 1 h at 37 C in pure FCS, washed, and used. 
Results
Characteristics of vertically HIV-infected children. The 18 HIV-positive children in the study were stratified in 2 groups: 6 HAART-treated children with clinical evidence of LD and 12 HAART-treated children without clinical evidence of LD (table 1). All patients in whom clinical LD was diagnosed had the following signs: peripheral lipoatrophy (sunken cheeks, buttocks, and limb atrophy) and truncal lipohypertrophy (increased abdominal girth). These signs were associated with breast enlargement in 2 patients, buffalo hump in 2 patients, and breast enlargement and buffalo hump in 1 patient. The 2 groups of children were similar in age, body mass index (BMI), and clinical and immunologic stage of disease. There were no statistically significant differences between LD-positive and LD-negative children for duration of previous exposure to NRTIs (zidovudine or zidovudine + didanosine), duration of current use of NRTIs and PIs (stavudine + lamivudine + nelfinavir, ritonavir, or indinavir), type of PI currently used, number and percentage of CD4 cells, or percentage of patients with undetectable HIV load. Changes in fat distribution in LD children. To confirm the clinical diagnosis of LD, DXA scans were performed in the 6 LD-positive children, and the results were compared with those for 6 HCs matched for age, sex, and BMI. In LD-positive children and HCs, fat mass (F) and distribution were significantly different, but lean mass (L) was similar (table 2) . Thus, in LDpositive children, the percentage F:L ratio was reduced (P ¼ :005), the F limbs:F trunk ratio was reduced (P ¼ :001), the F trunk:F total ratio was increased (P ¼ :001), and the F limbs:F total ratio was reduced (P , :0001).
Cytofluorimetric analysis. Cytofluorimetric analysis was performed on cells from all HIV-positive children and HCs. Table 3 shows the percentages of cells with depolarized mitochondria or in early or late apoptosis. Of note, all of these percentages were quite low and were similar in unstimulated PBL of LD-positive and -negative children and HCs. A slight change in Dc and early apoptosis occurred after stimulation with different compounds but at comparable extent in PBL of all 3 groups of children, as shown by staining with JC-1 or with ANX-V plus MT. Also, the percentage of late apoptotic PBL was similar in all 3 groups, both in unstimulated cells and in cells stimulated with anti-CD95 MAb, anti-CD3 MAb, or SEB. Figure 1 shows the distribution of CL in the mt inner membrane of PBL and monocytes and granulocytes from children with or without LD. No significant differences were found in this parameter, and it was remarkably similar to that of HCs (not shown).
Quantification of mtDNA content. By using an original approach based on QC-PCR, we measured the amount of mtDNA in 5 LD-positive children, 3 LD-negative children, and 6 HCs. As shown in figure 2 , there was relevant variability in the number of copies of mtDNA per cell, but overall there were no relevant differences among the groups.
Discussion
In recent years, antiretroviral therapy has provided consistent immunologic, virologic, and clinical benefits to HIV-infected children. Survival of vertically HIV-infected children significantly improved during 1996-1998, after the introduction of combined antiretroviral therapies. A recent study found .30% reduction in the risk of death for children at risk during 1996-1998 versus those at risk in 1980-1989 [29] .
A sustained suppression of HIV replication through potent antiretroviral therapy may be achieved in pediatric patients [30] . Children treated with HAART exhibit a high potential to reconstitute naive CD4 cells, even when they have advanced disease. This pattern of immune restoration differs from that in adults, perhaps because young patients still have a functioning thymus [31] [32] [33] . However, in childhood, anti-HIV treatment with PIs and/or NRTIs can cause LD [7] . The pathogenesis of this syndrome remains largely unknown, and different, but not mutually exclusive, hypotheses have been proposed that could explain, at least in part, the role of antiretroviral therapies. On the one hand, PI could bind and inhibit human proteins that share a high homology with HIV protease, such as the lowdensity lipoprotein receptor-related protein and the cytoplasmic retinoic acid-binding protein type 1 [4, 5] . The inhibition of the activity of these enzymes provokes profound changes in lipid metabolism, including hyperlipidemia, insulin Table 2 . Demographic, anthropometric, and body composition characteristics of children with lipodystrophy (LD) who were vertically infected with the human immunodeficiency virus and are receiving highly active antiretroviral therapy and of their pair-matched healthy control subjects (HCs). resistance, and adipocyte apoptosis [34] . On the other hand, NRTIs can either inhibit g-polymerase, a crucial enzyme for mtDNA replication [35] , or directly damage mtDNA [36] .
mtDNA is present in several copies in a single organelle that contains genes for crucial enzymes of the respiratory chain. Damages to mtDNA cannot be repaired in most cells because of the lack of an adequate set of enzymes, ultimately causing a decrease in energy metabolism. Moreover, these organelles control lipid metabolism, because they remove from plasma albumin-bound fatty acids that derive from hydrolysis of triglycerides and that undergo, when incorporated into these organelles, a process called b-oxidation, which ultimately generates ATP. ) lipodystrophy. Each bar represents 1 subject and indicates percentage of cardiolipin present in outer leaflet of mitochondrial inner membrane. There were no significant differences between the 2 groups, whose cardiolipin distribution was similar to that among healthy control subjects (not shown). Mitochondria are also a main target of tumor necrosis factor (TNF)-a [37] [38] [39] , whose homeostasis is dysregulated after HAART. HAART is associated with progressive accumulation of cells producing TNF-a, a phenomenon that is likely related to escape from apoptosis and linked to the cosynthesis of interleukin-2 [40] . As such, TNF-a leads to fat wasting and hyperlipidemia by inhibiting the activity of lipoprotein lipase and the intake of free fatty acids by adipocytes and by increasing the hepatic synthesis of triglycerides and thus lipogenesis, respectively [41] . Moreover, TNF-a triggers the production of leptin [42] , which, in turn, down-regulates lipogenic enzymes and is implicated in insulin resistance [43] .
The effects of antiretroviral drugs on mitochondria are now being investigated-many years after pivotal studies showed that an NRTI such as zidovudine was capable of causing myopathy, with abnormal mitochondria showing paracrystalline inclusions [44] , and able to reduce mtDNA content in cells of zidovudine-treated patients [45] . Less is known regarding possible direct effects of PIs on mitochondria. To our knowledge, there are no data from in vitro human cellular models. Thus, even if consistent reasons for drug-or virus-induced mt damages in the pathogenesis of LD have been hypothesized, there is a substantial lack of direct analysis of the functionality of these organelles.
In the present study, we used a variety of approaches: flow cytometric analysis of Dc and intra-mt CL distribution and quantification of mtDNA by QC-PCR to evaluate the possible presence of mt damage in the lymphocytes of LD children. mt functionality and tendency to undergo apoptosis were similar in PBL of LD-positive and -negative children receiving HAART and in HCs. Moreover, mtDNA content was similar in PBL of LD-positive children and HCs. In our patients, the diagnosis of LD was highly accurate and was based not only on clinical data but also on objective measurements. In fact, body composition was markedly different in LD-positive children from that in HCs and was characterized by peripheral lipoatrophy with truncal lipohypertrophy. Therefore, our data seem to exclude the presence of HAART-induced mt damage in lymphocytes from children with LD. However, several non-mutually exclusive hypotheses can be put forward to explain our results.
First, in HAART-treated patients, numerous lymphocytes are newly generated into the thymus [46] . This is particularly relevant in persons with a functioning organ (e.g., children) [33] . Thus, it is reasonable to assume that the period during which these cells were exposed to drugs was not sufficient to induce relevant damages. Second, unless activated, PBL are not very active and have a low metabolism rate, which is likely mirrored by low mt activity and ATP production. Thus, it can be assumed that the replication rate of children's mtDNA is not particularly high and, as a consequence, that there is a low incorporation of damaging drugs into mtDNA and a low requirement for gpolymerase. Third, the number of mitochondria per cell is low. By confocal microscopy, each resting lymphocyte has no more than 15-20 organelles. Fourth, the amount of mtDNA found in lymphocytes of LD-positive children and in HCs was surprisingly high (i.e., several hundred copies/cell). During aging there are significative changes in mtDNA, although precise quantitative data are lacking. Accordingly, preliminary data from our group, obtained by use of lymphocytes from donors of advanced age (.100 years), suggest that such reduction is consistent and that the number of copies of mtDNA is less than half that in children. Furthermore, we cannot exclude the possibility that the cells we analyzed were not the optimal model for studies of the effects of mitochondria-affecting drugs, because of not yet identified characteristics of organelles in immune cells.
In HIV-infected persons and in control donors, lymphocytes or other cells that can be obtained from peripheral blood are clearly the tissue of choice with regard to ease of sampling and analysis. However, methods used to isolate white blood cells from buffy coat or lymphocytes and monocytes by gradient density centrifugation do not completely remove platelets that are rich in mtDNA. In fact, after a standard PBL isolation, one can have up to 30 platelets per lymphocyte, which is not acceptable for proper quantification of mtDNA (authors' unpublished data). Thus, the platelets must be eliminated by additional passages, slow centrifugation and incubation in serum, or lymphocyte sorting. If fat is the site of lipodystrophic changes, it may show changes not observable in PBL. In pediatric patients, it is difficult to obtain samples from other tissues than blood, and some procedures raise ethical issues. Thus, further studies, either functional or molecular, are needed to clarify the role of mitochondria in LD.
